Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traystman, R. J.
Right arrow Articles by Hurn, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traystman, R. J.
Right arrow Articles by Hurn, P. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Behavioral Changes and Stroke
Right arrow Neuroprotectors
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Stroke. 2001;32:783.)
© 2001 American Heart Association, Inc.


Original Contributions

Anticonvulsant Lamotrigine Administered on Reperfusion Fails To Improve Experimental Stroke Outcomes

Richard J. Traystman, PhD; Judith A. Klaus, RN; A. Courtney DeVries, PhD; Amanda B. Shaivitz, BS Patricia D. Hurn, PhD

From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Md.

Correspondence to Richard J. Traystman, PhD, Distinguished University Research Professor Vice Chairman, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Blalock 1408, 600 N Wolfe St, Baltimore, MD 21287. E-mail rtraystm{at}@jhmi.edu

Background and Purpose—Recent results suggest that selective inhibitors of presynaptic neuronal ion channels can diminish glutamate release during cerebral ischemia and modulate excitotoxic cell death. The aim of the present study was to evaluate lamotrigine (LTG), an antiepileptic that inhibits presynaptic sodium and voltage-sensitive calcium channels, as a potential stroke resuscitation agent in the rat. Three dosages of LTG were examined for effect on infarction volume and sensorimotor behavioral recovery after middle cerebral artery (MCA) occlusion.

Methods—Halothane-anesthetized male Wistar rats were subjected to 2 hours of MCA occlusion by the intraluminal occlusion technique. Physiological variables were controlled, and ipsilateral cortical perfusion was monitored by laser Doppler flowmetry throughout ischemia. At onset of reperfusion, rats received intravenous LTG 5, 10, or 20 mg/kg or PBS (n=9 to 11 per group) during 15 minutes. Behavioral assessment was completed at 3 and 7 days after stroke, and the brain was harvested for histology (triphenyltetrazolium chloride staining).

Results—Values are mean±SE. Cortical infarction volumes were unchanged in LTG-treated animals: 14±6% of contralateral cortex at 5 mg/kg LTG, 17±7% at 10 mg/kg, and 30±6% at 20 mg/kg, versus saline-treated cohorts (12±3%; P=0.19; n=9). Caudate-putamen infarction injury was also unchanged (37±11% of contralateral caudate-putamen at 5 mg/kg LTG, 44±8% at 10 mg/kg, and 65±9% at 20 mg/kg versus saline (38±11%; P=0.18). Total infarction was not different among groups (P=0.15). Consistent with histology, behavioral outcomes were unimproved by treatment.

Conclusions—Histological damage and behavioral recovery at 7 days after MCA occlusion was not altered by LTG treatment over the dosage range used in the present study.


Key Words: anticonvulsant • cerebral ischemia, focal • cerebral ischemia, transient • stroke, experimental • stroke, ischemic • triazine




This article has been cited by other articles:


Home page
NeurologyHome page
P. Ryvlin, A. Montavont, and N. Nighoghossian
Optimizing therapy of seizures in stroke patients
Neurology, December 26, 2006; 67(12_suppl_4): S3 - S9.
[Abstract] [Full Text]


Home page
StrokeHome page
A. M. Naidech, K. T. Kreiter, N. Janjua, N. Ostapkovich, A. Parra, C. Commichau, E. S. Connolly, S. A. Mayer, and B.-F. M. Fitzsimmons
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke, March 1, 2005; 36(3): 583 - 587.
[Abstract] [Full Text] [PDF]